Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Adriaan Bins

Adriaan Bins

Person: Academic

No photo of Epie Boven

Epie Boven

Person: Academic

19972019
No photo of Cyrillo Brahm

Cyrillo Brahm

Person: Academic

20172018

Research Output 1988 2019

89 Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo

Jauw, Y., o'Donoghue, J., Zijlstra, J., Hoekstra, O., Menke-van der Houven van Oordt, C. W., Morschhauser, F., Carrasquillo, J., Zweegman, S., Pandit-Taskar, N., Lammertsma, A., van Dongen, G., Boellaard, R., Weber, W. & Huisman, M., 30 May 2019, In : Journal of Nuclear Medicine. p. jnumed.118.224568

Research output: Contribution to journalArticleAcademicpeer-review

89Zr-labeled bispecific T-cell engager AMG 211 PET shows AMG 211 accumulation in CD3-rich tissues and clear, heterogeneous tumor uptake

Moek, K. L., Waaijer, S. J. H., Kok, I. C., Suurs, F. V., Brouwers, A. H., Menke-van der Houven van Oordt, C. W., Wind, T. T., Gietema, J. A., Schröder, C. P., Mahesh, S. V. K., Jorritsma-Smit, A., Lub-de Hooge, M. N., Fehrmann, R. S. N., de Groot, D. J. A. & de Vries, E. G. E., 2019, In : Clinical Cancer Research. 25, 12, p. 3517-3527

Research output: Contribution to journalArticleAcademicpeer-review

Biochemically silent sympathetic Paraganglioma, Pheochromocytoma or Metastatic Disease in SDHD mutation carriers

Dreijerink, K. M. A., Rijken, J. A., Compaijen, C. J. A. C., Timmers, H. J. L. M., van der Horst-Schrivers, A. N. A., van Leeuwaarde, R. S., Sytze van Dam, P., Leemans, C. R., van Dam, E. W. C. M., Dickhoff, C., Dommering, C. J., de Graaf, P., Zwezerijnen, G. J. C. B., van der Valk, P., Menke-Van der Houven van Oordt, C. W., Hensen, E. F., Corssmit, E. P. M. & Eekhoff, E. M. W., 13 Jun 2019, In : The Journal of clinical endocrinology and metabolism.

Research output: Contribution to journalArticleAcademicpeer-review

Activities 2017 2017

  • 1 Oral presentation

Rapid development of peritoneal metastases after adjuvant chemotherapy is associated with worse survival after cytoreduction and HIPEC.

NR Sluiter (Speaker), Y Salhi (Speaker), G Kazemier (Speaker), HMW Verheul (Speaker), JB Tuynman (Speaker)
Sep 2017

Activity: Talk or presentationOral presentation